DGF may have been correct in claiming the Haifa filing was designed to steal the IP.
Here's a refresher from Michael Feldenkrais CEO of CATV, a company under FBI investigation:
Michael Feldenkrais, CEO of Can IT Industries, Inc. comments: "Can It is seeking to change the current guesswork involved in deciding how to treat disease using Medicinal Cannabis. Patients seeking to employ medicinal cannabis as a treatment are faced with unreliable cannabis products from most dispensaries and the uncertainty as to what compounds to use. As such the company has licensed and signed agreements with state of the art technologies like OWC and others that provide a 360 degree approach to achieve this goal."
"The company has been gathering formulations in 3rd Phase Clinical trials and distributing in the Western Hemisphere," Feldenkrais adds. "Our strategy considers the mitigation of the environmental risks involved in cultivation of Cannabis by using the correct genetics to create the best medicines for individualized treatment."
Feldenkrais continues: "Can IT accomplishes its goals in three steps: assembling the most current and proven medicinal cannabis research and clinical studies. Second, it leverages both pre-eminent medicinal cannabis experts and machine learning platforms to analyze data and standardize medicinal cannabis compounds. Third, Can IT uses proven data and expert analysis to develop validated personalized medicinal cannabis treatment recommendations for our patient-members and their healthcare providers and enable access to reliable partner dispensaries to obtain the proper cannabis compound ratios and dosages. We are proud to announce our agreement with OWC as part of our strategy to achieve our goals."
Anyone know why Turner didn't issue an 8-k for the material event highlighted in red?
Market Data 
Markets 
AI
